Biotech. Suggested holding: BiolineRx (BLRX), an Israeli micro-cap that's aiming to find better treatment for pancreatic cancer, which is currently a death sentence for 95%+ of those diagnosed. Major milestones are ahead, including the most important readout of its Phase 3 clinical trial by the end of Q1. Huge risk (!), but an even greater potential reward.